Cancer Screening
Our Private GP clinic is in easy reach from High Wycombe, Marlow, Oxford and Thame, being just 1 minute off Junction 5 of the M40. We offer an extensive range of vaccinations and travel services.
Why Cancer Screening?
Welcome to 222 Healthcare, at the forefront of advanced cancer screening services. We go beyond traditional health screenings, offering a comprehensive range of biochemical testing conducted in the comfort of a Private GP clinic.
Benefits of Early Detection
Early detection saves lives. Detecting cancer in its early stages improves treatment success rates, minimises invasive procedures, and enhances overall well-being.
Result Review by Our GPs
As a private GP services, we prioritise your health at every step. All the test results are being reviewed by one of our experienced GPs.
How to Get Tested
Getting screened is easy. The clinic will provide you with a testing kits, and instructions alongside. Our nurses are available to assist you throughout the entire process.
Advice for Next Steps
You will be advised on the next procedure after getting the results, and individual health circumstances.
Personalised Review
Our GPs will provide feedback on your test results
Our Location
Just 1 minute off the M40. Close proximity to High Wycombe, Marlow, Thame, Oxford, Aylesbury, Maidenhead and Beaconsfield (and more).
Bowel Cancer FIT
FIT detects human blood in stool. Its role depends on whether it is being used for screening or symptomatic assessment; a result does not diagnose or rule out bowel cancer.
PSA Prostate Blood Test
PSA testing has potential benefits and harms, including false positives and overdiagnosis. An informed decision is important, particularly without symptoms.
Cervical HPV Screening
Cervical screening is a preventive test, not a diagnostic test for symptoms. Testing method, intervals and eligibility must be confirmed for the offered service.
CA125 Ovarian Assessment
CA125 is not recommended as a routine screening test for asymptomatic people at average risk. Results must be interpreted alongside symptoms and other investigations.
Stockholm3 Advanced Prostate Cancer Risk Test
Stockholm3 combines blood biomarkers, genetic variants and clinical history to estimate risk of clinically significant prostate cancer. Intended for males aged 45–74 without previous prostate cancer, with PSA >1.5 ng/mL.…
BRCA1 & BRCA2 Genetic Testing
BRCA1 and BRCA2 testing looks for inherited genetic variants associated with increased risks of certain cancers, particularly breast and ovarian cancer, and some prostate and pancreatic cancers. It does not detect an exi…